Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optimal dosing of broad-spectrum β-lactams in obese infected patients
2011-004239-29Phase 4Completed
- Sponsor
- Erasmus Hospital
- Start
- Sep 2011
- Modality
- Reversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules, Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of piperacillin + tazobactam, tazobactam, piperacillin, ceftazidime in bacterial disease, sponsored by Erasmus Hospital. Started Sep 2011; status: completed.
02
Drugs
03
Conditions
bacterial disease
Beyond the preview
Go deeper on 2011-004239-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-004239-29.